California Rx Discount Legislation Repelled, But Not Necessarily Dead
Executive Summary
The defeat of two California ballot initiatives that would have created a drug discount program will not deter the propositions' backers from pursuing similar legislation through the traditional legislative process
You may also be interested in...
Manufacturer Patient Assistance Programs To Change Following IG Guidance
An HHS Office of Inspector General "1special advisory bulletin" on manufacturer-sponsored patient assistance programs for Medicare Part D beneficiaries will force companies to restructure these programs
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials